Intraoperative Neuromonitoring Market Size, Share & Trends Analysis Report By Product (Insourced, Outsourced), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Intraoperative Neuromonitoring Market Growth & Trends
The global intraoperative neuromonitoring market size is anticipated to reach USD 4.65 billion by 2030, registering a CAGR of 4.9% during the forecast period, according to a new report published by Grand View Research, Inc. This growth can be attributed to technological advancements, increasing awareness regarding the safety of the devices, and the growing geriatric population. The COVID-19 outbreak is expected to have a dual impact on the market. In March 2020, the American College of Surgeons (ACS) published a proposal to reduce, postpone, or cancel elective surgeries as COVID-19 cases grew quickly in the U.S., which is expected to hamper growth.
Moreover, according to a research study published in Elsevier journal (International Hemorrhagic Stroke Association; Jan 2021), up to 36% of hospitalized COVID-19 patients might exhibit neurological symptoms, and there were several cases related to ischemic & hemorrhagic infarction. In addition, another recent research study published in Neurology Online Journal in June 2021 proposed that the COVID-19 virus might be responsible for patients acquiring novel neurological diseases. Owing to the growth of new diseases, there is a higher risk of in-hospital mortality and a low discharge rate. These characteristics are expected to result in lucrative growth over the forecast period.
Furthermore, the market is expected to witness growth due to the increasing number & affordability of neurosurgeries and the growing emphasis on patient safety in surgeries. Hospitals are adopting Intraoperative Neuromonitoring (IONM) in a wide spectrum of surgeries, as it reduces the number of revision surgeries and results in fewer postoperative complications & cases of permanent impairment.
Intraoperative Neuromonitoring Market Report Highlights
Intraoperative Neuromonitoring Market Growth & Trends
The global intraoperative neuromonitoring market size is anticipated to reach USD 4.65 billion by 2030, registering a CAGR of 4.9% during the forecast period, according to a new report published by Grand View Research, Inc. This growth can be attributed to technological advancements, increasing awareness regarding the safety of the devices, and the growing geriatric population. The COVID-19 outbreak is expected to have a dual impact on the market. In March 2020, the American College of Surgeons (ACS) published a proposal to reduce, postpone, or cancel elective surgeries as COVID-19 cases grew quickly in the U.S., which is expected to hamper growth.
Moreover, according to a research study published in Elsevier journal (International Hemorrhagic Stroke Association; Jan 2021), up to 36% of hospitalized COVID-19 patients might exhibit neurological symptoms, and there were several cases related to ischemic & hemorrhagic infarction. In addition, another recent research study published in Neurology Online Journal in June 2021 proposed that the COVID-19 virus might be responsible for patients acquiring novel neurological diseases. Owing to the growth of new diseases, there is a higher risk of in-hospital mortality and a low discharge rate. These characteristics are expected to result in lucrative growth over the forecast period.
Furthermore, the market is expected to witness growth due to the increasing number & affordability of neurosurgeries and the growing emphasis on patient safety in surgeries. Hospitals are adopting Intraoperative Neuromonitoring (IONM) in a wide spectrum of surgeries, as it reduces the number of revision surgeries and results in fewer postoperative complications & cases of permanent impairment.
Intraoperative Neuromonitoring Market Report Highlights
- By type, the insourced segment accounted for the largest share of 55.19% in 2021. This can be attributed to growing awareness among physicians as well as patients about the benefits of IONM, which results in the hospitals utilizing IONM during complex procedures. This is a key reason for the dominance of insourced IONM in the market
- By region, North America accounted for the largest share of 49.30% in 2021. Favorable reimbursement scenarios along with technological advancements can be attributed to this dominance
- Asia Pacific is expected to witness the fastest CAGR of 5.46% over the forecast period. The growing geriatric population, increasing number of surgeries, and rising expenditure on healthcare can be attributed to this growth
CHAPTER 1. METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Type
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3. INTRAOPERATIVE NEUROMONITORING MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List Of Key End Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increased Awareness and Benefits of IONM
3.5.1.2 Application of IONM to Broader Types of Surgeries
3.5.1.3 Increasing Initiatives By Governments And Organizations
3.5.2 Market Restraints Analysis
3.5.2.1 Lack of Trained Personnel and Knowledge Gap 3.5.2.2 High Cost
3.6 Intraoperative Neuromonitoring: Market Analysis Tools
3.6.1 Industry Analysis – Porter’s
3.6.2 SWOT Analysis, by Pest
3.7 Impact Of COVID-19 On Market & Post Pandemic Insights
CHAPTER 4. INTRAOPERATIVE NEUROMONITORING MARKET: SEGMENT ANALYSIS, BY TYPE 2017 - 2030 (USD MILLION)
4.1 Definition and Scope
4.2 Type Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Intraoperative Neuromonitoring Market, by Type, 2017 To 2030
4.5 Market Size & Forecasts and Trend Analyses, 2017 To 2030
4.5.1 Insourced
4.5.1.1 Insourced Market, 2017–2030 (USD Million)
4.5.2 Outsourced
4.5.2.1 Outsourced Market, 2017–2030 (USD Million)
CHAPTER 5. INTRAOPERATIVE NEUROMONITORING MARKET: REGIONAL MARKET ANALYSIS, BY TYPE 2017 - 2030 (USD MILLION)
5.1 Definition & Scope
5.2 Regional Market Share Analysis, 2021 & 2030
5.3 Regional Market Dashboard
5.4 Regional Market Snapshot
5.5 Market Size, & Forecasts, Volume and Trend Analysis, 2021 To 2030
5.6 North America
5.6.1 North America Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.6.2 U.S.
5.6.2.1 U.S. Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.6.3 Canada
5.6.3.1 Canada Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.7 Europe
5.7.1 Europe Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.7.2 U.K.
5.7.2.1 U.K. Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.7.3 Germany
5.7.3.1 Germany Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.7.4 France
5.7.4.1 France Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.7.5 Italy
5.7.5.1 Italy Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.7.6 Spain
5.7.6.1 Spain Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.8 Asia Pacific
5.8.1 Asia Pacific Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.8.2 Japan
5.8.2.1 Japan Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.8.3 China
5.8.3.1 China Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.8.4 India
5.8.4.1 India Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.8.5 Australia
5.8.5.1 Australia Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.8.6 South Korea
5.8.6.1 South Korea Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.9 Latin America
5.9.1 Latin America Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.9.2 Brazil
5.9.2.1 Brazil Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.9.3 Mexico
5.9.3.1 Mexico Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.9.4 Argentina
5.9.4.1 Argentina Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.9.5 Colombia
5.9.5.1 Colombia Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.10 MEA
5.10.1 MEA Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.10.2 South Africa
5.10.2.1 South Africa Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.10.3 Saudi Arabia
5.10.3.1 Saudi Arabia Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.10.4 UAE
5.10.4.1 UAE Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
CHAPTER 6. INTRAOPERATIVE NEUROMONITORING MARKET - COMPETITIVE ANALYSIS
6.1 Recent Developments & Impact Analysis, by Key Market Participants
6.2 Company Categorization
6.2.1 Innovators
6.2.2 Market Leaders
6.3 Vendor Landscape
6.3.1 Key Company Market Share Analysis, 2021
6.3.2 Major Deals and Strategic Alliances
6.3.2.1 New Product Launch
6.3.2.2 Expansion
6.3.2.3 acquisition
6.3.3 Market Entry Strategies
6.4 Company Profiles
6.4.1 Natus Medical Incorporated
6.4.1.1 Company Overview
6.4.1.2 Financial Performance
6.4.1.3 Product Benchmarking
6.4.1.4 Strategic Initiatives
6.4.2 Accurate Monitoring
6.4.2.1 Company Overview
6.4.2.2 Financial Performance
6.4.2.3 Product Benchmarking
6.4.2.4 Strategic Initiatives
6.4.3 Neuromonitoring Technologies
6.4.3.1 Company Overview
6.4.3.2 Financial Performance
6.4.3.3 Product Benchmarking
6.4.3.4 Strategic Initiatives
6.4.4 Biotronic NeuroNetwork, Llc
6.4.4.1 Company Overview
6.4.4.2 Financial Performance
6.4.4.3 Product Benchmarking
6.4.4.4 Strategic Initiatives
6.4.5 Medtronic
6.4.5.1 Company Overview
6.4.5.2 Financial Performance
6.4.5.3 Product Benchmarking
6.4.5.4 Strategic Initiatives
6.4.6 NuVasive, Inc
6.4.6.1 Company Overview
6.4.6.2 Financial Performance
6.4.6.3 Product Benchmarking
6.4.6.4 Strategic Initiatives
6.4.7 SpecialtyCare
6.4.7.1 Company Overview
6.4.7.2 Financial Performance
6.4.7.3 Product Benchmarking
6.4.7.4 Strategic Initiatives
6.4.8 Sentient Medical Systems
6.4.8.1 Company Overview
6.4.8.2 Financial Performance
6.4.8.3 Product Benchmarking
6.4.8.4 Strategic Initiatives
1.1 Market Segmentation & Scope
1.1.1 Type
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3. INTRAOPERATIVE NEUROMONITORING MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List Of Key End Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increased Awareness and Benefits of IONM
3.5.1.2 Application of IONM to Broader Types of Surgeries
3.5.1.3 Increasing Initiatives By Governments And Organizations
3.5.2 Market Restraints Analysis
3.5.2.1 Lack of Trained Personnel and Knowledge Gap 3.5.2.2 High Cost
3.6 Intraoperative Neuromonitoring: Market Analysis Tools
3.6.1 Industry Analysis – Porter’s
3.6.2 SWOT Analysis, by Pest
3.7 Impact Of COVID-19 On Market & Post Pandemic Insights
CHAPTER 4. INTRAOPERATIVE NEUROMONITORING MARKET: SEGMENT ANALYSIS, BY TYPE 2017 - 2030 (USD MILLION)
4.1 Definition and Scope
4.2 Type Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Intraoperative Neuromonitoring Market, by Type, 2017 To 2030
4.5 Market Size & Forecasts and Trend Analyses, 2017 To 2030
4.5.1 Insourced
4.5.1.1 Insourced Market, 2017–2030 (USD Million)
4.5.2 Outsourced
4.5.2.1 Outsourced Market, 2017–2030 (USD Million)
CHAPTER 5. INTRAOPERATIVE NEUROMONITORING MARKET: REGIONAL MARKET ANALYSIS, BY TYPE 2017 - 2030 (USD MILLION)
5.1 Definition & Scope
5.2 Regional Market Share Analysis, 2021 & 2030
5.3 Regional Market Dashboard
5.4 Regional Market Snapshot
5.5 Market Size, & Forecasts, Volume and Trend Analysis, 2021 To 2030
5.6 North America
5.6.1 North America Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.6.2 U.S.
5.6.2.1 U.S. Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.6.3 Canada
5.6.3.1 Canada Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.7 Europe
5.7.1 Europe Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.7.2 U.K.
5.7.2.1 U.K. Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.7.3 Germany
5.7.3.1 Germany Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.7.4 France
5.7.4.1 France Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.7.5 Italy
5.7.5.1 Italy Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.7.6 Spain
5.7.6.1 Spain Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.8 Asia Pacific
5.8.1 Asia Pacific Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.8.2 Japan
5.8.2.1 Japan Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.8.3 China
5.8.3.1 China Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.8.4 India
5.8.4.1 India Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.8.5 Australia
5.8.5.1 Australia Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.8.6 South Korea
5.8.6.1 South Korea Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.9 Latin America
5.9.1 Latin America Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.9.2 Brazil
5.9.2.1 Brazil Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.9.3 Mexico
5.9.3.1 Mexico Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.9.4 Argentina
5.9.4.1 Argentina Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.9.5 Colombia
5.9.5.1 Colombia Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.10 MEA
5.10.1 MEA Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.10.2 South Africa
5.10.2.1 South Africa Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.10.3 Saudi Arabia
5.10.3.1 Saudi Arabia Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
5.10.4 UAE
5.10.4.1 UAE Intraoperative Neuromonitoring Market 2017 - 2030 (USD Million)
CHAPTER 6. INTRAOPERATIVE NEUROMONITORING MARKET - COMPETITIVE ANALYSIS
6.1 Recent Developments & Impact Analysis, by Key Market Participants
6.2 Company Categorization
6.2.1 Innovators
6.2.2 Market Leaders
6.3 Vendor Landscape
6.3.1 Key Company Market Share Analysis, 2021
6.3.2 Major Deals and Strategic Alliances
6.3.2.1 New Product Launch
6.3.2.2 Expansion
6.3.2.3 acquisition
6.3.3 Market Entry Strategies
6.4 Company Profiles
6.4.1 Natus Medical Incorporated
6.4.1.1 Company Overview
6.4.1.2 Financial Performance
6.4.1.3 Product Benchmarking
6.4.1.4 Strategic Initiatives
6.4.2 Accurate Monitoring
6.4.2.1 Company Overview
6.4.2.2 Financial Performance
6.4.2.3 Product Benchmarking
6.4.2.4 Strategic Initiatives
6.4.3 Neuromonitoring Technologies
6.4.3.1 Company Overview
6.4.3.2 Financial Performance
6.4.3.3 Product Benchmarking
6.4.3.4 Strategic Initiatives
6.4.4 Biotronic NeuroNetwork, Llc
6.4.4.1 Company Overview
6.4.4.2 Financial Performance
6.4.4.3 Product Benchmarking
6.4.4.4 Strategic Initiatives
6.4.5 Medtronic
6.4.5.1 Company Overview
6.4.5.2 Financial Performance
6.4.5.3 Product Benchmarking
6.4.5.4 Strategic Initiatives
6.4.6 NuVasive, Inc
6.4.6.1 Company Overview
6.4.6.2 Financial Performance
6.4.6.3 Product Benchmarking
6.4.6.4 Strategic Initiatives
6.4.7 SpecialtyCare
6.4.7.1 Company Overview
6.4.7.2 Financial Performance
6.4.7.3 Product Benchmarking
6.4.7.4 Strategic Initiatives
6.4.8 Sentient Medical Systems
6.4.8.1 Company Overview
6.4.8.2 Financial Performance
6.4.8.3 Product Benchmarking
6.4.8.4 Strategic Initiatives
LIST OF TABLES
Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. North America intraoperative neuromonitoring market, by country 2017 - 2030 (USD Million)
Table 4. North America intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 5. U.S. intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 6. Canada intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 7. Europe intraoperative neuromonitoring market, by country 2017 - 2030 (USD Million)
Table 8. Europe intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 9. U.K. intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 10. Germany intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 11. France intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 12. Italy intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 13. Spain intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 14. Asia Pacific intraoperative neuromonitoring market, by country 2017 - 2030 (USD Million)
Table 15. Asia Pacific intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 16. China intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 17. Japan intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 18. India intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 19. Australia intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 20. South Korea intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 21. Latin America intraoperative neuromonitoring market, by country 2017 - 2030 (USD Million)
Table 22. Latin America intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 23. Brazil intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 24. Mexico intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 25. Argentina intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 26. Colombia intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 27. Middle East & Africa intraoperative neuromonitoring market, by country 2017 - 2030 (USD Million)
Table 28. Middle East & Africa intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 29. South Africa intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 30. Saudi Arabia intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 31. UAE intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. North America intraoperative neuromonitoring market, by country 2017 - 2030 (USD Million)
Table 4. North America intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 5. U.S. intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 6. Canada intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 7. Europe intraoperative neuromonitoring market, by country 2017 - 2030 (USD Million)
Table 8. Europe intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 9. U.K. intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 10. Germany intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 11. France intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 12. Italy intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 13. Spain intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 14. Asia Pacific intraoperative neuromonitoring market, by country 2017 - 2030 (USD Million)
Table 15. Asia Pacific intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 16. China intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 17. Japan intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 18. India intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 19. Australia intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 20. South Korea intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 21. Latin America intraoperative neuromonitoring market, by country 2017 - 2030 (USD Million)
Table 22. Latin America intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 23. Brazil intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 24. Mexico intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 25. Argentina intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 26. Colombia intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 27. Middle East & Africa intraoperative neuromonitoring market, by country 2017 - 2030 (USD Million)
Table 28. Middle East & Africa intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 29. South Africa intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 30. Saudi Arabia intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
Table 31. UAE intraoperative neuromonitoring market, by type 2017 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Intraoperative neuromonitoring market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2021)
Fig. 10 Segment outlook
Fig. 11 Strategy framework
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Consumer behavior analysis
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Intraoperative neuromonitoring market: Type movement analysis
Fig. 19 Segment dashboard
Fig. 20 Intraoperative neuromonitoring market type outlook: Key takeaways
Fig. 21 Insourced market 2017 - 2030 (USD Million)
Fig. 22 Outsourced market 2017 - 2030 (USD Million)
Fig. 23 Regional outlook, 2021 & 2030
Fig. 24 Regional market dashboard
Fig. 25 Regional marketplace: Key takeaways
Fig. 26 North America intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 27 U.S. intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 28 Canada intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 29 Europe intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 30 U.K. intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 31 Germany intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 32 France intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 33 Italy intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 34 Spain intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 35 Asia Pacific intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 36 Japan intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 37 China intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 38 South Korea intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 39 Indonesia intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 40 Australia intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 41 India intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 42 Latin America intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 43 Brazil intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 44 Mexico intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 45 Argentina intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 46 Colombia intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 47 MEA intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 48 South Africa intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 49 Saudi Arabia intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 50 UAE intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 51 Company market share analysis, 2021
Fig. 52 Market differentiators
Fig. 53 Regional network map
Fig. 1 Intraoperative neuromonitoring market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2021)
Fig. 10 Segment outlook
Fig. 11 Strategy framework
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Consumer behavior analysis
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Intraoperative neuromonitoring market: Type movement analysis
Fig. 19 Segment dashboard
Fig. 20 Intraoperative neuromonitoring market type outlook: Key takeaways
Fig. 21 Insourced market 2017 - 2030 (USD Million)
Fig. 22 Outsourced market 2017 - 2030 (USD Million)
Fig. 23 Regional outlook, 2021 & 2030
Fig. 24 Regional market dashboard
Fig. 25 Regional marketplace: Key takeaways
Fig. 26 North America intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 27 U.S. intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 28 Canada intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 29 Europe intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 30 U.K. intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 31 Germany intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 32 France intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 33 Italy intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 34 Spain intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 35 Asia Pacific intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 36 Japan intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 37 China intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 38 South Korea intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 39 Indonesia intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 40 Australia intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 41 India intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 42 Latin America intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 43 Brazil intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 44 Mexico intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 45 Argentina intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 46 Colombia intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 47 MEA intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 48 South Africa intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 49 Saudi Arabia intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 50 UAE intraoperative neuromonitoring market 2017 - 2030 (USD Million)
Fig. 51 Company market share analysis, 2021
Fig. 52 Market differentiators
Fig. 53 Regional network map
